Kaleo Release: Pharma Announces U.S. Availability And Pricing To Patients Of AUVI-Q (Epinephrine Injection, USP) Auto-Injector, For Life-Threatening Allergic Reactions Post author:Sam Post published:January 18, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Catabasis To Present Results From The Open-Label Extension Of The Movedmd Phase II Trial Of Edasalonexent In Duchenne Muscular Dystrophy In A Late Breaking Session Of The World Muscle Society September 14, 2017 SPR Therapeutics Promotes To SVP Of Research And Development September 6, 2017 Keystone Nano Announces Start Of Clinical Testing Of Ceramide NanoLiposome For The Improved Treatment Of Cancer April 6, 2017
Catabasis To Present Results From The Open-Label Extension Of The Movedmd Phase II Trial Of Edasalonexent In Duchenne Muscular Dystrophy In A Late Breaking Session Of The World Muscle Society September 14, 2017
Keystone Nano Announces Start Of Clinical Testing Of Ceramide NanoLiposome For The Improved Treatment Of Cancer April 6, 2017